Panitan Pradubpongsa

Bangkok, Thailand

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications

Disseminated Histoplasmosis and Campylobacter jejuni Bacteremia Coinfection Revealing Autosomal Dominant NFKB1 Deficiency-Related Common Variable Immunodeficiency.

Disseminated Histoplasmosis and Campylobacter jejuni Bacteremia Coinfection Revealing Autosomal Dominant NFKB1 Deficiency-Related Common Variable Immunodeficiency.

Journal: Medical mycology journal
Published: November 30, 2025

Randomized, Double-Blind, Placebo-Controlled Trial of Vitamin D Supplementation in the Build-up Phase of House Dust Mite-Specific Immunotherapy.

Randomized, Double-Blind, Placebo-Controlled Trial of Vitamin D Supplementation in the Build-up Phase of House Dust Mite-Specific Immunotherapy.

Journal: Allergy, asthma & immunology research
Published: June 28, 2022

Switching from subcutaneous to sublingual immunotherapy during the maintenance phase in patients with house dust mite allergy.

Switching from subcutaneous to sublingual immunotherapy during the maintenance phase in patients with house dust mite allergy.

Journal: Allergy
Published: June 02, 2022

Bifidobacterium infantis 35624 efficacy in patients with uncontrolled asthma: A randomized placebo-controlled trial.

Bifidobacterium infantis 35624 efficacy in patients with uncontrolled asthma: A randomized placebo-controlled trial.

Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
Published: May 28, 2022

Increased circulating CRTH2+ Tregs are associated with asthma control and exacerbation.

Increased circulating CRTH2+ Tregs are associated with asthma control and exacerbation.

Journal: Allergy
Published: July 15, 2021

Successful treatment of atopic dermatitis with house dust mite sublingual immunotherapy tablets.

Successful treatment of atopic dermatitis with house dust mite sublingual immunotherapy tablets.

Journal: Asian Pacific journal of allergy and immunology
Published: July 11, 2021

IL-10-producing innate lymphoid cells increased in patients with house dust mite allergic rhinitis following immunotherapy.

IL-10-producing innate lymphoid cells increased in patients with house dust mite allergic rhinitis following immunotherapy.

Journal: The Journal of allergy and clinical immunology
Published: March 30, 2020

Allergen-specific immunotherapy boosts allergen-specific IgD production in house dust mite-sensitized asthmatic patients.

Allergen-specific immunotherapy boosts allergen-specific IgD production in house dust mite-sensitized asthmatic patients.

Journal: Allergy
Published: October 08, 2019

Der p 1-specific regulatory T-cell response during house dust mite allergen immunotherapy.

Der p 1-specific regulatory T-cell response during house dust mite allergen immunotherapy.

Journal: Allergy
Published: August 08, 2018

Features and outcomes of immunoglobulin therapy in patients with Good syndrome at Thailand's largest tertiary referral hospital.

Features and outcomes of immunoglobulin therapy in patients with Good syndrome at Thailand's largest tertiary referral hospital.

Journal: Asian Pacific journal of allergy and immunology
Published: June 12, 2018

Decreased CRTH2 Expression and Response to Allergen Re-stimulation on Innate Lymphoid Cells in Patients With Allergen-Specific Immunotherapy.

Decreased CRTH2 Expression and Response to Allergen Re-stimulation on Innate Lymphoid Cells in Patients With Allergen-Specific Immunotherapy.

Journal: Allergy, asthma & immunology research
Published: April 28, 2018

Role of Der p 1-specific B cells in immune tolerance during 2 years of house dust mite-specific immunotherapy.

Role of Der p 1-specific B cells in immune tolerance during 2 years of house dust mite-specific immunotherapy.

Journal: The Journal of allergy and clinical immunology
Published: February 27, 2018
Showing 1-12 of 17

Last Updated: 09/26/2026